Trinity Biotech (TRIB) Receivables Refunds (2016 - 2025)
Historic Receivables Refunds for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $431000.0.
- Trinity Biotech's Receivables Refunds rose 22900.76% to $431000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $431000.0, marking a year-over-year increase of 22900.76%. This contributed to the annual value of -$486000.0 for FY2024, which is 72372.88% down from last year.
- Per Trinity Biotech's latest filing, its Receivables Refunds stood at $431000.0 for Q2 2025, which was up 22900.76% from $518000.0 recorded in Q4 2024.
- Trinity Biotech's 5-year Receivables Refunds high stood at $2.9 million for Q1 2021, and its period low was -$192000.0 during Q4 2022.
- In the last 5 years, Trinity Biotech's Receivables Refunds had a median value of $518000.0 in 2024 and averaged $1.0 million.
- In the last 5 years, Trinity Biotech's Receivables Refunds crashed by 9936.56% in 2023 and then skyrocketed by 261818.18% in 2024.
- Over the past 5 years, Trinity Biotech's Receivables Refunds (Quarter) stood at -$167000.0 in 2021, then decreased by 14.97% to -$192000.0 in 2022, then skyrocketed by 889.58% to $1.5 million in 2023, then plummeted by 65.83% to $518000.0 in 2024, then fell by 16.8% to $431000.0 in 2025.
- Its Receivables Refunds was $431000.0 in Q2 2025, compared to $518000.0 in Q4 2024 and $226000.0 in Q3 2024.